Intraoperative dialysis with the use of a mobile dialysis system during liver transplantation.


Journal

Advances in medical sciences
ISSN: 1898-4002
Titre abrégé: Adv Med Sci
Pays: Netherlands
ID NLM: 101276222

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 01 10 2021
revised: 22 03 2022
accepted: 29 04 2022
pubmed: 15 5 2022
medline: 26 10 2022
entrez: 14 5 2022
Statut: ppublish

Résumé

Over the last few years, transplant centers have started to use various intraoperative renal replacement therapy (ioRRT) modalities during liver transplantation (LT) in patients with pre-existing renal impairment. Here, we present a study on the safety and clinical outcomes of intraoperative hemodialysis (ioHD) performed using a mobile dialysis system during LT. We retrospectively analyzed 102 adult patients undergoing LT with ioHD; pre-existing renal failure and/or intraoperative metabolic derangement were ioHD treatment indications. Our study cohort consisted of three groups: LT with preoperative serum creatinine (sCr) ​< ​2 ​mg/dL (Group 1:n ​= ​22), LT with preoperative sCr ≥2 ​mg/dL (Group 2:n ​= ​73), and simultaneous liver-kidney transplantation (Group 3:n ​= ​7). Among the procedures, 30% were re-transplantations. The mean calculated Model for End-stage Liver Disease score in Group 2 was 39.2, and 67% of patients were hospitalized in the intensive care unit. Patients in Group 1 were less acutely ill but developed severe intraoperative derangements and, therefore, underwent urgent ioHD intraoperatively. However, it was delayed when compared to Group 2. All groups achieved post-reperfusion potassium levels <4 ​mmol/L and a decrease in central venous pressure. No serious procedural complications occurred. Post-reperfusion syndrome occurred in 12.7% of patients. Elevated mortality was likely due to the high illness severity in the cohort. Performing ioHD with a mobile dialysis system during LT was safe and effective, while being easier to perform than continuous techniques. Its effect on intra- and postoperative outcomes should be addressed in a study with a control group.

Identifiants

pubmed: 35568010
pii: S1896-1126(22)00018-9
doi: 10.1016/j.advms.2022.04.004
pii:
doi:

Substances chimiques

Creatinine AYI8EX34EU
Potassium RWP5GA015D

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

208-215

Informations de copyright

Copyright © 2022. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no conflict of interests.

Auteurs

Małgorzata Kościelska (M)

Department of Nephrology, Dialysis and Internal Diseases, Medical University of Warsaw, Warsaw, Poland.

Joanna Matuszkiewicz-Rowińska (J)

Department of Nephrology, Dialysis and Internal Diseases, Medical University of Warsaw, Warsaw, Poland.

Dorota Giercuszkiewicz (D)

Department of Anaesthesiology and Intensive Care, Medical University of Warsaw, Warsaw, Poland.

Marek Krawczyk (M)

Department of General, Liver and Transplantation Surgery, Medical University of Warsaw, Warsaw, Poland.

Grzegorz Niewiński (G)

Department of Anaesthesiology and Intensive Care, Medical University of Warsaw, Warsaw, Poland.

Janusz Sierdziński (J)

Department of Medical Informatics and Telemedicine, Medical University of Warsaw, Warsaw, Poland.

Krzysztof Zieniewicz (K)

Department of General, Liver and Transplantation Surgery, Medical University of Warsaw, Warsaw, Poland.

Paweł Żebrowski (P)

Department of Nephrology, Dialysis and Internal Diseases, Medical University of Warsaw, Warsaw, Poland.

Jolanta Małyszko (J)

Department of Nephrology, Dialysis and Internal Diseases, Medical University of Warsaw, Warsaw, Poland. Electronic address: jolmal@poczta.onet.pl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH